Don gyara shingen fata, masana'antun a da sun fi mai da hankali kan sake cika mai da ruwa, kamar "zane bango." Duk da haka, manyan masana'antun kayan masarufi yanzu suna haɓaka sabuwar dabara: gyara na gaske yana farawa da inganta fata. Katangar garkuwar jiki.
A shekarar 2026, ilimin fata na duniya ya ci gaba da zurfafa bincike kan matakin injiniya, yana canza matakan gargajiya waɗanda za su iya samar da gyaran matakin saman kawai. A yau, gasar fasaha don gyaran shingen fata ta zama wani aiki mai rikitarwa na injiniyan tsari - wanda ba wai kawai ya dogara da daidaita sinadarai da yawa ba har ma ya samar da "kwanƙolin" fasaha ga masana'antun.
Kwanan nan, babban kamfanin kayan masarufi dsm-firmenich an kaddamar da shi Glycare™ SK, wani sabon dandamali wanda ya dogara da Oligosaccharides na Madarar Dan Adam (HMOs)Sinadaran da aka saki a lokaci guda, Sabuntawar Glycare™ SK da kuma Glycare™ SK Jin Daɗi, kai tsaye tura gyaran shingen fata zuwa wani sabon mataki na rigakafi na ciki da kuma daidaita ƙwayoyin cuta.
Kashi na 01: Daga Gyaran Fuska zuwa Tsarin Tsabtace Fata Mai Zurfi
Na dogon lokaci, fahimtar da masana'antar kula da fata ta duniya ta yi game da shingen fata ta dogara ne akan Samfurin "Bulo da Turmi" [1]. A zahiri, duk da haka, halayen fata sun fi rikitarwa fiye da yadda wannan samfurin ya nuna.
Dangane da hanyar gargajiya: Yawancin masana'antun suna gyara shingen fata ta hanyar sake cika ceramides, fatty acids, da cholesterol. Duk da cewa wannan dabarar sake cikawa da aka yi niyya tana da tasiri, a zahiri tana magance alamun maimakon tushen dalilin - matsalolin da ke cikinta ba a warware su ba.
Matsalar da ta fi daukar hankali a nan ita ce: Binciken likitanci na zamani ya gano cewa saboda sake dawowa da saurin kamuwa da fata da lalacewar shinge, tushen abin da ke haifar da hakan yana cikin yawan kunna martanin garkuwar jiki na fata da rashin daidaito na ƙwayoyin cuta [2]. Ba za a iya magance waɗannan matsalolin masu zurfi ta hanyar hanyoyin kula da fata na gargajiya ba.
A cewar wani bincike da aka gudanar a cikin Jaridar Binciken Dermatology, lokacin da epidermis ya lalace, ƙwayoyin keratinocytes suna fitar da abubuwan sigina kamar IL-1α da TSLP (Thymic Stromal Lymphopietin) [3]. Bugu da ƙari, idan shingen fata ya lalace kuma matakan pH suka tashi, Staphylococcus aureus Yawaita da yawa. Bincike ya tabbatar da cewa yana iya fitar da proteases kai tsaye don lalata filaggrin na fata. Dangane da wannan, Nature ya wallafa cewa bambancin ƙwayoyin cuta a cikin marasa lafiya da ke fama da atopic dermatitis (matsanancin hankali) yana da ƙasa sosai, sau da yawa tare da mamayewar ƙwayoyin cuta Staphylococcus aureus [4]
Bincike daga mujallu masu iko kamar Jaridar Binciken Dermatology yana nuna cewa akwai sigina tsakanin ƙwayoyin fata na commensal da keratinocytes. Idan wannan daidaito ya lalace, fatar ta ci gaba da kasancewa cikin yanayi mai matuƙar saurin kamuwa da kumburi, koda kuwa an cika lipids ta amfani da hanyoyin gargajiya.
Dalilan da ke cikin wannan Glycare™ SK ya bambanta da hanyoyin gargajiya. Ta hanyar kwaikwayon hanyoyin kariya na matakan farko na rayuwa, yana amfani da kwayar siginar da ke aiki sosai -HMO—don sake daidaita juriyar garkuwar fata, yana bawa fata damar samun daidaito a hankali.
Kashi na 02: HMO—“Kyawun Kimiyyar Fata”
Madarar ɗan adam Oligosaccharides (HMOs) sune sinadari na uku mafi girma a cikin madarar nono.
1. Tsarin Kimiyya [5]
Littattafan kimiyya sun nuna cewa HMOs ba abu ɗaya ba ne amma sun ƙunshi fiye da ƙwayoyin carbohydrates masu rikitarwa 200. Suna da wani abu na musamman "Mai karɓar na'urar lalata" aiki:
Tasirin hana mannewa: Tsarin kwayoyin halittar HMOs yayi kama da masu karɓar ƙwayoyin halitta a saman ƙwayoyin halitta na fata. Kwayoyin cuta masu cutarwa suna ɗaurewa da ƙwayoyin HMO ba bisa ka'ida ba maimakon masu karɓar ƙwayoyin halitta na ainihi. Sakamakon haka, ƙwayoyin cuta masu cutarwa suna kasancewa a kan fatar jiki, ba za su iya mannewa da ƙwayoyin halitta ba, kuma daga ƙarshe ana wanke su ta hanyar metabolism na fata na yau da kullun.
Ka'idar rigakafi: A matsayin prebiotics, HMOs suna haɓaka haɓakar ƙwayoyin cuta masu amfani (kamar su Bifidobacterium da kuma nau'ikan da ke da alaƙa) kuma suna ɗaure kai tsaye ga masu karɓar ƙwayoyin rigakafi don hana sakin abubuwan da ke haifar da kumburi [6].
2. Daidaito na Haɗawa: Daga Dakin Gwaji zuwa Masana'antu
dsm-firmenich yana amfani da Daidaitaccen Haki don cimma yawan samar da ƙwayoyin HMO guda biyu masu mahimmanci a cikin kasuwanci: 2'-Fucosyllactose (2'-FL) da kuma Lacto-N-neotetraose (LNnT).
Abin lura shi ne, bin ƙa'idodinsa abin birgewa ne. Duk da cewa an sanya musu suna Human Milk Oligosaccharides, suna da suna iri ɗaya. ba daga asalin ɗan adam ba, suna mai da su masu ɗabi'a da tsarki [7]. Suna amfani da whey drop-products a matsayin substrates kuma ana samar da su a Turai ta amfani da makamashin da ake sabuntawa.
1) Daidaitowar Hadin Girki
Mataki na 1: Tsarin "Shirye-shiryen" na Halitta: Masana kimiyya sun fara nazarin tsarin kwayoyin halitta na HMOs a cikin madarar nono. Sannan, an dasa gutsuttsuran kwayoyin halitta da ke iya hada wadannan kwayoyin sukari cikin kwayoyin halitta masu aminci.
Mataki na 2: Ingantaccen "Kiwo": Da zarar an gyara su, waɗannan ƙananan halittu suna da ƙwarewa ta musamman don samar da HMOs masu yawa. Suna zama "injinan da suka dace" musamman don haɗa 2′-FL ko LNnT.
Mataki na 3: Rufe jiki: Ana sanya waɗannan ƙananan ƙwayoyin cuta da aka gyara ta hanyar wucin gadi a cikin manyan tankunan fermentation na bakin ƙarfe. dsm-firmenich yana amfani da lactose daga whey cikin hikima a matsayin "abinci."
2) Sarrafawa a Ƙasa
A lokacin samarwa, masana'antun suna sarrafa zafin jiki, pH, da iskar oxygen sosai, wanda hakan ke ba ƙwayoyin cuta damar cinye lactose da kuma haɗa ƙwayoyin HMO tsarkakakku. Bayan fermentation, tankin yana ɗauke da gaurayen ƙwayoyin cuta da hadaddun metabolites. Don samun tsarki mai kyau na kayan kwalliya, ana buƙatar cirewa mai tsauri sosai:
Rabuwar ƙwayoyin halitta: Ana cire ƙwayoyin cuta ta hanyar amfani da hanyoyin kamar ultrafiltration.
Gyaran Launi da Ƙarfafawa: Ana cire launuka da ma'adanai da aka samar yayin girki.
Tsarkakewa Mai Kyau: Samfurin ƙarshe bai ƙunshi wani abu da ɗan adam ya samo ba kuma babu DNA daga ƙwayoyin cuta da aka gyara ta hanyar halitta.
Busar da Crystallization da Bushewa: Sakamakon shine farin foda ko ruwa mai tsabta (sama da kashi 95%-98%) na HMO.
Sashe na 03: Shaidar Asibiti—Tsaron da ke da Alaƙa da Bayanan Bayanai
Dandalin Glycare™ SK yana ba da tallafin bayanai na gwaji ga buƙatun fata daban-daban:
Sabuntawar Glycare™ SK: Gyara Mai Zurfi da Hana Tsufa
Ga fatar da ta lalace sosai, Renew yana nuna ƙarfin sake gina fata. Bayanan In vitro sun nuna cewa tana iya ƙaruwa sosai. Matakan collagen na nau'in I da kashi 67%, wanda ba wai kawai yana gyara shingen ba, har ma yana ƙara kauri ga ma'aunin fata.
Aikin Asibiti (makonni 8):
TEWL (Rashin Ruwa na Transepidermal) ya ragu ta hanyar 19%.
Ganuwa redness rage ta 38%, yana inganta yawan launin fata da kuma telangiectasia wanda kumburi mai tsanani ke haifarwa [8].
Jin Daɗin Glycare™ SK: Tsaron Yau da Kullum da Kwantar da Hankali Mai Dorewa
Ta hanyar mayar da hankali kan matsalolin "fatar da ke da rauni" tsakanin masu amfani da matsakaicin matsayi na birane, Comfort ta mayar da hankali kan kiyaye yanayin jiki.
Ruwan Ruwa Nan take: Yawan ruwan fata ya ƙaru ta hanyar 13% cikin sati 4.
Haɗakar Shinge: Asarar ruwa ta ragu da 16% cikin sati 8.
Taimakon Hankali: Ta hanyar daidaita ƙwayoyin cuta masu rai (microbiome), yana rage yawan jin zafi da abubuwan da ke haifarwa daga waje ke haifarwa sosai.
| tsarin awo | Sabuntawar Glycare™ SK | Glycare™ SK Jin Daɗi |
| Babban Fa'idodi | Ginawa mai zurfi, hana kumburi, haɓaka collagen | Ruwan sha mai ɗorewa na dogon lokaci, yanayin narkewar microbiome |
| Ragewar TEWL | Kashi 19% (makonni 8) | Kashi 16% (makonni 8) |
| Inganta Ja | Kashi 38% (makonni 8) | Ingantaccen ci gaba |
| Bayanai na Musamman | Nau'in I Collagen + 67% | Ruwan da ke cikinsa +13% (makonni 4) |
Kashi na 04: Binciken Yanayin Masana'antu—Shin Kwayoyin cuta da Kariya Su Ne Babban Buri Na Gaba?
A halin yanzu, HMOs sun riga sun zama "abin sha'awa" a cikin manyan samfuran jarirai. Duk da haka, a cikin tsarin kula da fata, HMOs har yanzu sabon abu ne.
Saboda tsarin hada HMOs mai rikitarwa, wanda ba wai kawai yana buƙatar tsarki mai tsanani ba, har ma da kwanciyar hankali a cikin tsari, wannan yana bawa masana'antun damar samun "kwanƙolin" fasaha mai girma.
A takaice:
Dandalin Glycare™ SK daga dsm-firmenich ba wai kawai ƙaddamar da wani sinadari ba ne, har ma isar da wani maganin gyaran garkuwar jiki na biomimeticBayyanar sa yana nuna cewa kula da fata yana tafiya zuwa ga "Zamanin Hankali na Halittu." Ga masu mallakar samfuran da ke neman bambancin gasa, babu shakka HMOs su ne babban nau'in nauyi na gaba tare da goyon bayan kimiyya mai ƙarfi da fahimtar mabukaci, suna bin ilimin halittar roba da kuma collagen mai sake haɗawa.
Leecosmetic: Amfani da albarkatun kasa daga sanannun kamfanoni na duniya
Tuntuɓi: https://leecosmetic.com/contactus/
Tushen Bayani Mai Iko:
[1] Elias, PM (1983). Aikin shingen epidermal: bambance-bambancen hulɗa tsakanin mutane da nau'ikan halittu. Jaridar Binciken Dermatology.
[2] Belkaid, Y., & Harrison, OJ (2017). Garkuwar Gida da Kwayoyin Halittu. rigakafi.
[3] Ziegler, SF (2012). Thymic stromal lymphopoietin (TSLP): wani babban mai kula da cututtukan rashin lafiyan. Jaridar Binciken Dermatology.
[4] Byrd, AL, da sauransu (2018). Kwayoyin halittar fata ta ɗan adam. Nature Reviews Microbiology.
[5] Bode, L. (2012). Madarar ɗan adam oligosaccharides: Kowane jariri yana buƙatar uwa mai sukari. Glycobiology.
[6] Triantis, V., da sauransu (2018). Tasirin Rigakafin Kwayoyin Halittar Madarar Dan Adam Oligosaccharides. Iyaka a Likitan Yara.
[7] dsm-firmenich Takardar Farin Fasaha (2025). Daidaito da Tsarin Haɗawa da Sauƙaƙa Tsarin HMOs don Amfani da Jiki.
[8] Rahoton Nazarin Asibiti na Glycare™ SK (2025). Ingancin 2′-FL da LNnT a Gyaran Katangar Fata da Rage Ja.
